ClinicalTrials.Veeva

Menu

A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities (LINKED-HEARTS)

Johns Hopkins University logo

Johns Hopkins University

Status

Enrolling

Conditions

Chronic Kidney Diseases
Hypertension
Diabetes
High Blood Pressure

Treatments

Behavioral: LINKED-HEARTS Program

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05321368
P50MD017348 (U.S. NIH Grant/Contract)
IRB00311760

Details and patient eligibility

About

The LINKED- HEARTS Program is a multi-level project that intervenes at the practice level by linking home blood pressure monitoring (HBPM) with a telemonitoring platform (Sphygmo). The program incorporates team-based care by including community health workers (CHWs) and pharmacists to improve the outcomes of multiple chronic conditions (reduced blood pressure (BP), lower blood sugar, and improved kidney function). The LINKED-HEARTS Program will recruit a total of 600 adults with uncontrolled hypertension (BP ≥ 140/90 mm Hg) AND either type 2 diabetes or chronic kidney disease (CKD) across 16 community health centers or primary care practices serving high-risk adults. This cluster-randomized trial consists of two arms: (1) enhanced "usual care arm," wherein patients will be provided with Omron 10 series home BP monitors and will be managed by the patients' primary care clinicians as usual; and (2) the "intervention arm" which will integrate HBPM telemonitoring, a CHW intervention and provider-level interventions into the usual clinical care to improve BP control and provide support for self-management of chronic conditions. The study pharmacist will conduct telehealth, use the Sphygmo app and the Pharmacist Patient Care Process to collaborate with other providers to optimize pharmacologic therapy to improve hypertension outcomes and with payors to ensure consistent access to drug therapy.

Enrollment

425 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. 18 years of age as of date of data extraction,
  2. Self-identify as non-Hispanic white, non-Hispanic Black/African American and/or Hispanic,
  3. Diagnosis of Hypertension (HTN) defined by International Classification of Diseases, Tenth code (ICD-10 code) and elevated systolic blood pressure (SBP) measure (≥140 mm Hg) on their most recent clinic visit.
  4. Diagnosis of diabetes or chronic kidney disease (both defined by ICD-10 code), in addition to HTN
  5. Receives primary medical care at one of the participating health systems
  6. Have a Maryland and D.C. home address

Exclusion criteria

  1. Age <18 years
  2. Diagnosis of end-stage renal disease (ESRD) treated with dialysis
  3. Serious medical condition which either limits life expectancy or requires active management (e.g., cancer)
  4. Cognitive impairment or other condition preventing participation in the intervention
  5. Planning to leave the practice or move out of the geographic area in 24 months
  6. No longer consider the practice site their location for primary care
  7. Unwillingness to provide informed consent

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

425 participants in 2 patient groups

LINKED-HEARTS Program
Experimental group
Description:
Patients in the LINKED-HEARTS Program will be trained to measure their blood pressure with an Omron 10 series device using the Sphygmo telemonitoring app. The physician, pharmacist and Community Health Worker will have access to transmit data. Community Health Workers will provide education on managing blood pressure; reinforce positive blood pressure self-management behaviors; deliver knowledge and skills to promote healthy chronic conditions; assist with linking clinical and administrative services; and link participants with community resources. The study pharmacist will conduct telehealth visits, optimize pharmacologic therapy. The pharmacists will assess and address medication adherence to improve hypertension and diabetes control.
Treatment:
Behavioral: LINKED-HEARTS Program
Enhanced Usual Care
No Intervention group
Description:
Patients in the Enhanced Usual Care Arm, will receive care as usual from their primary care provider and will be trained to measure their blood pressure with an Omron 10 series device. The staff in each participating community health center practice will be trained in blood pressure measurement best practices.

Trial contacts and locations

3

Loading...

Central trial contact

Yvonne Commodore-Mensah, PhD, MSH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems